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Abstract
Background: Tuberculosis (TB) causes 1.45 million deaths annually world wide, the majority of which occur in the
developing world. Active TB disease represents immune failure to control latent infection from airborne spread. Acid-fast
bacillus (AFB) seen on sputum smear is a biomarker for contagiousness.
Methods: We enrolled 73 tuberculosis patients with extensive infiltrates into a research study using bronchoalveolar lavage
(BAL) to sample lung immune cells and assay BAL cell cytokine production. All patients had sputum culture demonstrating
Mycobacterium tuberculosis and 59/73 (81%) had AFB identified by microscopy of the sputum. Compared with smear
negative patients, smear positive patients at presentation had a higher proportion with smoking history, a higher
proportion with temperature .38.50 C, higher BAL cells/ml, lower percent lymphocytes in BAL, higher IL-4 and IL-12p40 in
BAL cell supernatants. There was no correlation between AFB smear and other BAL or serum cytokines. Increasing IL-4 was
associated with BAL PMN and negatively associated with BAL lymphocytes. Each 10-fold increase in BAL IL-4 and IL-12p40
increased the odds of AFB smear positivity by 7.4 and 2.2-fold, respectively, in a multi-variable logistic model.
Conclusion: Increasing IL-4 and IL-12p40 production by BAL cells are biomarkers for AFB in sputum of patients who present
with radiographically advanced TB. They likely reflect less effective immune control of pathways for controlling TB, leading
to patients with increased infectiousness.
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Introduction
The global plan for tuberculosis (TB) by the Stop TB
Partnership is to halve the prevalence and mortality caused by
TB by 2015, followed by eliminating TB as a public health
problem by 2050. [1] Tuberculosis is an infection spread through
the air. TB patients frequently cough and generate aerosols of
Mycobacterium tuberculosis (Mtb) that dry and produce suspended
fomites. Once inhaled, the Mtb lodges in an unexposed person’s
lung, rehydrates and starts to replicate slowly. A TB specific Th1
immune response develops, preventing active tuberculosis but
failing to eradicate all viable Mtb, producing latent tuberculosis
infection (LTBI). Approximately 10% of HIV negative LTBI
patients develop active TB over the course of their lives. With HIV
co-infection, a large majority of those with LTBI will develop
active disease [2]. In high TB burden countries like South Africa,
approximately 40–50% of the population has LTBI and 1% of the
population of South Africa developed active TB in 2009 producing
an annual incidence of 480,000 cases [3].
The mycolic acid of Mtb cell walls appears bright red with Ziehl-
Neelsen stain that is also called acid fast stain. Mtb is the most
common acid fast staining bacillus (AFB). Observing AFB on
microscopic examination of the sputum in a patient with
pulmonary infiltrates and cavities is consistent with tuberculosis;
culture of Mtb and/or molecular diagnostics confirms the
diagnosis. While AFB staining is less sensitive and specific than
Mtb culture, the AFB test yields results in hours compared to the
weeks required for Mtb culture. In addition, the AFB smear is also
useful for measuring infectiousness. A patient with AFB smear
negative, culture positive TB has a low probability of transmitting
infection compared to a patient with smear positive TB [4,5].
The CD4+ Th1 lymphocyte response is required for effective
acquired immunity to Mtb [6]. Adding the Th1 cytokine interferon
gamma by aerosol improves response to therapy by more rapidly
converting the sputum smear from positive to negative and
reducing respiratory symptoms [7]. Alternatively, patients with
mutations in Th-1 cytokine signaling pathways such as interferon
gamma and IL-12 (a p40 and p35 heterodimer) are susceptible to
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overwhelming infection with Mtb [8,9]. Impaired CD4+ Th1
lymphocyte response in HIV infection also produces ineffective
immunity to Mtb [2]. Several observations suggest that the Th2
cytokines, IL-4 and IL-10, are associated with LTBI reactivation
and advanced TB [10–13]. The antagonist splice variant IL-
4delta-2 reduces the risk of severe disease and reduced the risk of
progression to active disease in contacts of patients with active
disease [14–16]. Surprisingly, an IL-12p40 homodimer is
expressed in Th2 disease such as asthma [17].
To better understand the relation of immune state to TB
transmissibility in HIV negative patients who presented with
culture confirmed TB and extensive infiltrates/cavities, we studied
immune cells from the lower respiratory tract using BAL. We
performed a cross sectional study of an urban cohort in Cape
Town presenting with extensive infiltrates and many with at least
one cavity. We observed that increasing release of IL-4 and IL-
12p40 by BAL cells were risk factors for being AFB smear positive.
These results suggest immune pathways that are Th2-like with
increased IL-4 and IL-12 p40 release are associated with increased
infectiousness.
Methods
Study Subjects: Patients with pulmonary tuberculosis were
recruited from April 2005 to December 2006 in the Division of
Pulmonology at the University of Cape Town with the following
inclusion criteria [7]: All patients had Mtb cultured from their
sputum, were drug-sensitive and had extensive infiltrates. Age,
gender, race/ethnicity, fever, respiratory symptoms, and smoking
status were obtained at screening evaluation. BMIs were
calculated from height and weight measured at screening. Sputum
smear was performed at the time of bronchoscopy two weeks after
screening. IRB approval was obtained at NYU School of Medicine
and the University of Cape Town; all study subjects signed
informed consent in their native language.
Bronchoalveolar lavage (BAL): BAL was performed after local
anesthesia with lidocaine; the bronchoscope was inserted via the
nasal passage to the lower respiratory tract, wedged, and a 300-ml
lavage was performed using 5, 20-ml aliquots of normal saline in
each of three involved lung segments. The recovered fluid was
pooled and filtered over sterile gauze, and a total cell count
performed. A cytospin slide was stained with Diff-Quik and 500
cells counted to determine the cell differential. BAL supernatants
were cultured in RPMI over 24 hours at 106 BAL cells/ml. BAL
cell supernatants were thawed once at 4uC and assayed using 13-
Plex Human Pro-inflammatory Panel according to manufacturer’s
instructions (Millipore, Billerica, MA). The supernatants were
analyzed on a Luminex 200IS (Luminex Corporation, Austin, TX)
using MasterPlex TM QT software (Ver. 1.2; MiraiBio, Inc).
Statistical Analysis: Database management and statistics were
performed using SPSS 20 (IBM, Armonk, NY). Normally
distributed data were expressed as mean and standard deviation.
Data not distributed normally and multi-analyte comparisons were
evaluated using a Mann Whitney U-test. Hierarchical clustering
was performed using furthest neighbor squared Euclidean distance
with Z-score transformed variables. Analytes that were signifi-
cantly different between smear positive and negative were used to
construct logistic regression models with AFB smear status as the
outcome variable. The models were adjusted for potential
confounders that were chosen after the study was completed.
BMI was chosen because malnutrition is strongly immune-
compromising, smoking status was significantly different between
smear positive and smear negative patients. Gender and race were
added because of different potential differences in environmental
exposures. Significance was assessed at p,0.05.
Results
By design all 73 patients in this cohort had culture positive
pulmonary tuberculosis with extensive infiltrates on their chest x-
rays. The group was young with a median age of 34 years and was
75% male. Black Africans accounted for 41% of the cohort while
patients reporting more than one race accounted 59%. They were
underweight with a median BMI of 18.7. A large proportion (77%)
had a history of current smoking. They uniformly had reactivity to
tuberculin skin testing (25 mm). A minority (41%) had fever on
presentation or cavities on chest x-ray (31%) (Table 1).
Our primary outcome was bacterial burden as assessed by AFB
on sputum smear. At presentation 59/73 (81%) had high bacterial
burden (smear positive) with AFB observed on sputum microscopy
and 14/73 (19%) had low bacterial burden with no AFB observed
in sputum (smear negative). Those with fever and ever smokers
were more likely to be AFB smear positive (48% vs. 14%, p,0.03
and 83% vs. 50%, p,0.01 respectively). There was no significant
association between smear status and age, gender, BMI, race,
tuberculin skin test (TST) size, or the presence of cavities on chest
x-ray (Table 1).
We assessed the immune response using BAL cell differential
and cytokine elaboration after 24 hours of ex vivo culture. AFB
smear positive patients had higher total BAL cells/ml (19.3 vs 15.6
x103/ml, p,0.03, Table 2). Alternatively AFB smear positive
patients had lower proportion of BAL lymphocytes (4% vs 10%,
p = 0.002, Table 2).
Cytokine elaboration in 24-hour culture supernatants was
measured by multiplex bead fluorescence assay. AFB smear
positive patients versus smear negative patients had significantly
higher IL-4 and IL-12p40 production (7.68 pg/ml vs. 2.6 pg/ml
p,0.01 and 102 pg/ml vs. 3.2 pg/ml p = 0.01, Table 3 respec-
tively). There was a trend to higher IL-10 elaboration in smear
positive patients (8.95 pg/ml vs. 6.09 pg/ml p = 0.068, Table 3).





Age* 35 (11) 30 (9) 0.118
Gender (Male){ 45 (76.3) 10 (71.4) 0.7051
BMI* 19.01 (2.55) 18.76 (2.54) 0.7471
Smoking (Ever){ 49 (83.1) 7 (50) 0.009
Race{ Black 24 (40.7) 6 (42.9)
.1 35 (59.3) 8 (57.1) 0.882
Other** 0 0
TST (mm)* 32 (15) 28 (10) 0.2571
Cavities on CXR 17 (28) 5 (36) 0.613
Fever{ 28 (47.5) 2 (14.3) 0.023
*Mean (SD);
{N(%).
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IFN-c elaboration between smear negative and smear positive
patients. There was a significant negative correlation between
BAL lymphocytes and IL-4 production (R2 = 0.09, p = 0.012). In
addition, there was a strong positive correlation between BAL
PMN and IL-4 (R2 = 0.354, p,0.0001, Figure 1). To assess the
contribution of environmental exposures to IL-4 production we
cultured BAL cells from 8 patients recruited from Cape Town with
clear chest x-rays. In the absence of stimulation, none had
measurable IL-4 levels using a high sensitivity IL-4 ELISA with a
limit of detection 0.25 pg/ml. As a positive control the cells were
treated with RD-1; after stimulation eighty seven percent 7/
8(87%) had IL-4 above the limit of detection with a mean level of
8.267.6pg/ml There was no significant correlation between BAL
cell differential and IL-6, IL-8, IL-10, TNF-a, IP-10 or IFN-c.
There was no correlation between BAL cell cytokine production
and serum cytokine levels (data not shown).
We used hierarchical clustering to determine the association
between immunologic, radiographic findings and AFB smear
status. AFB observed in induced sputum clustered with IL-4 and
IL-12p40. Consistent with the results of the linear regression, IL-4
and PMN clustered together (Figure 2). Even though there was
trend towards increased IL-10 in smear positive patients, it did not
cluster with the AFB smear. Interestingly, the Th-1 cytokines IFN-
c and IP-10 clustered together with TNF-a, another cytokine
important for effective TB immunity.
We then tested the ability of BAL cell cytokines to predict the
presence of AFB on examination of sputum smear (Table 4). Each
10-fold increase in IL-4 significantly increased the odds of AFB in
the sputum by 7.4-fold (95% CI 1.2–46) in a logistic model
adjusted for BMI, ethnicity, gender and smoking. Each 10-fold
increase in IL-12p40 also increased risk for positive AFB smear by
2.2-fold (95% CI 1.1–4.3). There was no association between IL-
10 and smear status (95% CI 0.45–23) (Table 4).
Discussion
We performed a cross sectional study of cytokine release into
24-hour BAL supernatants on 73 HIV-negative urban South
African patients who presented with pulmonary tuberculosis. All
had extensive infiltrates on chest x-ray and a significant minority
had cavities. They were severely underweight with median BMI of
18.9, but maintained active antigen-specific cellular immunity to
Mtb with strongly reactive tuberculin skin tests. The study cohort
represents young adults, a group whose reproductive and
economic potential is negatively impacted by TB. They put
contacts at home and at work at risk for Mtb exposure. An
improved understanding of the risk factors for transmission is




Cells/mL x 104 19.3 (12–33) 15.5 (6–17) 0.027
AM,% 60 (19–80) 62 (52–77) 0.330
Lymph,% 4 (2–8) 10 (6–15) 0.002
PMN, % 31 (10–79) 25 (9–38) 0.282
Eos, % – 1 (1–1) –
Data represented as Median(IQR) and significance measured by Mann-Whitney
U.
doi:10.1371/journal.pone.0059461.t002
Figure 1. Correlation of BAL supernatant IL-4 with BAL cell differential. A. Lymphocyte %. B. Polymorphonuclear Neutrophils %. Linear
regressions with 95% confidence intervals.
doi:10.1371/journal.pone.0059461.g001




IL-4 7.68 (2.3–16.8) 2.57 (1.7–6.2) 0.009
IL-6 5.89 (4.0–30.7) 5.95 (4.0–8.2) 0.597
IL-8 591.08 (230–2989) 448.5 (181–1060) 0.516
IL-10 8.95 (5.6–15.2) 6.09 (3.4–6.1) 0.068
IL-12(p40) 101.7 (3.2–299) 3.20 (0.6–75.3) 0.010
TNF-a 11.04 (4.5–39.1) 12.63 (3.5–25.4) 0.961
IP-10 24.39 (14.9–50.4) 19.36 (10.4–32.9) 0.408
IFN-c 10.43 (6.0–18.5) 3.77 (2.7–11.4) 0.111
Analytes are in Median (IQR); pg/mL.
Mann-Whitney U used to test of Significance.
doi:10.1371/journal.pone.0059461.t003
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therefore important. The infectivity of pulmonary tuberculosis was
ably described by Shaw and Wynn-Williams in London six
decades ago when smear positive cases resulted in 65% contact
conversion of tuberculin tests in children 0–14 years whereas
smear negative culture positive cases resulted in 27% conversion
and smear negative culture negative was 18% [4]. They reported
that 54/374 children who were close contacts of smear positive
source cases of tuberculosis developed active tuberculosis, com-
pared to 6/228 who were close contacts of smear negative and
culture positive patients (OR = 6.2, 95% CI 2.6–14.7).
In addition to routine clinical evaluation, we performed
research bronchoscopy to retrieve lung immune cells from the
site of infection. This allowed us to assess cytokine production and
BAL cell differential in association with sputum AFB smear status.
We observed that each 10-fold increase in production of the Th2
cytokine IL-4 increased the odds of being smear positive by 7.4-
fold. IL-10, another Th2 cytokine that is a TB biomarker, was not
a significant predictor of sputum AFB smear status in this cohort
suggesting that IL-4 is the predominant Th2 biomarker that
predicts poor TB control. Cytokine co-expression in human Th1/
Th2 cells differentiates in response to GATA3, T-bet, and other
transcription factors, with IL-4, IL-5, and IL-13 regulated by a
coordinated mechanism whereas IL-10 is expressed by a different
subset of cells that is prevalent at early stages of Th2 differentiation
[18]. Increased IL-4 gene expression in PBMCs has been found in
non-Beijing strains of TB associated with more cough, fever, night
sweats, advanced radiological disease, and cavities [19]. Increased
CD8+IL-4 T cells predicted progression from latent infection to
active disease in 6/10 health care workers [20]. We did not
measure the IL-4d2 splice variant which is an IL-4 antagonist and
is increased in BAL cells in TB/HIV co-infection [14,15].
IL-4 has been implicated in conversion of LTBI to active TB. It
has also been associated with radiographic extent of disease but
not AFB smear status [10]. We now report a strong positive
association between BAL-cell IL-4 production and the presence of
AFB on sputum smear. There was no association between BAL-
cell IL-4 and serum IL-4 levels suggesting the pulmonary
inflammation during TB is not accurately reflected in the systemic
compartment or venous blood. There was a negative association
between BAL IL-4 and BAL lymphocytes. This could underlie the
impact of IL-4 on sputum AFB since smear positive patients have
lower BAL lymphocytes than smear negative patients. Further
investigation of the impact of IL-4 production on lymphocyte
number and function in tuberculosis is needed to better
understand this observation. While smear status did not correlate
with PMN in the BAL, there was a strong positive linear
correlation between IL-4 and PMN in BAL. The proportion of
patients with elevated PMN in this cohort is noteworthy. Half the
patients had more than 25% PMN in their BAL cell differentials.
Only the lowest quartile had fewer than 10% PMN in their BAL.
Mtb inhibits both macrophage and PMN apoptosis leading to
delayed activation of naı̈ve CD4 cells [21]. We previously noted
that IL-8 in BAL fluid correlated with PMN in BAL from TB
patients [22], but we did not replicate this in BAL supernatants.
IL-4 has been postulated as a key player in TB pathogenesis,
especially with its ability to down-regulate inducible nitric oxide
synthase, Toll-like receptor 2, and macrophage activation [23].
Flow cytometric analysis of IL-4 production in CD8 and CD4 cells
in blood from TB patients showed increases in patients with
cavities although we did not find increased BAL supernatant IL-4
in our TB patients with cavities [24]. IL-4 mRNA in PBMC has
been associated with advanced pulmonary TB as well as a
subgroup with increased antagonist IL-4d2; the role of Th2
cytokines in human tuberculosis requires further investigation
[10].
We also observed that smear positive patients had higher IL12
p40 than smear negative patients (101 pg/ml vs 3.2 pg/ml
p,0.01). Each 10-fold increase in IL-12p40 production increased
the odds of being smear positive by 2.2-fold. The low level of IL-
12p40 production by BAL cells has been observed in patients with
minimal TB from Chandigarh, India [25] and in volunteers with
normal chest x-rays in New York [26]. The elevated BAL cell
production of IL-12p40 appears to occur during high burden
disease.
The observation that elevated IL-12p40 was a risk factor for
being smear positive was surprising since IL-12 is a Th1 cytokine
important for TB control in humans [8]. IL-12 is a heterodimer
made up of a p40 and p35 subunit. The p40 subunit has other
binding partners that lead to cytokines with varied functions. A
possible explanation for the finding is that IL-12p40 homodimers
form and function as a macrophage chemo-attractant as well as a
competitive antagonist of IL-12 [17,27,28]. In vivo IL-12p40
homodimers are elevated in asthma, a disease characterized by
Th2 hyperactivity. Our immunoassay did not give information on
the binding partner of IL-12p40 in this setting requiring further
investigation for a better understanding of this observation.
Immunohistochemistry of TB granulomas consistently showed
IL-12p40 in CD8+ cells; 75% of granulomas were positive for both
IFN-c and IL-12, and 4/7 TB patients expressed IL-4 and IFN-c
Figure 2. Hierarchical clustering of results from sputum smear
for AFB, BAL cell differential, BAL cell culture supernatants and
cavities on chest radiograph demonstrates AFB smear clusters
with IL-4, IL-12 p40 and BAL PMN.
doi:10.1371/journal.pone.0059461.g002
Table 4. Regression Analysis for AFB smear positive.
Analyte OR 95% CI
IL-4 7.382 1.19–45.97
IL-12 (p40) 2.176 1.09–4.34
Analytes pg/mL Log10.
Adjusted for BMI, Ethnicity, Gender and smoking Status (Ever/Never).
Hosmer-Lemeshow (Goodness of Fit) Sig. .0.05 for each single analyte model.
doi:10.1371/journal.pone.0059461.t004
Biomarkers of Tuberculosis Transmissibility
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in granulomas [29]. IL-12p40 is required for dendritic cell
migration and T cell priming after Mtb infection in transgenic
IL-12p402/2 mice [30]. IL-122/2 mice infected by airways
inoculation of BCG do not have macrophages, lymphocytes, or
Th1 cytokine responses, but do not have a Th2 response either
and succumb to local growth and systemic spread of bacilli [31].
A history of smoking, oral temperature greater than 38.5uC
upon enrollment and high BAL cell numbers were significantly
associated with being AFB smear positive. Nutritional state as
measured by BMI was not different between smear negative and
smear positive patients. The negative effects of smoking on lung
immunity in tuberculosis are well documented and demonstrated
in this study [32]. A systematic review and meta-analysis of 43
observational studies found smokers compared to people who do
not smoke, have an increased risk of a positive TST, of having
active TB (summary estimate of 2.01), and of dying of TB [32].
There were additional risks from passive cigarette smoke and
indoor air pollution from biomass burning. Smoking also
contributes to increased neutrophils in the BAL. Fever and
increased BAL cell concentration are non-specific markers on
inflammation. It is not surprising that patients with higher Mtb
burden have increased manifestations of inflammation. Tracey’s
group has shown that acetylcholine-producing memory T cells
activated by the vagus nerve via the a7-nicotinic acetylcholine
receptor inhibit TNF-a production in the spleen, and nicotine in
cigarette smoke can target the same receptor potentially inhibiting
TNF-a production, which is essential for protective host immunity
in TB [33].
This study has several limitations. It is a cross sectional natural
history investigation and the observed associations do not imply
causality. In addition, the findings on BAL-cell cytokine produc-
tion are unlikely to be clinically useful since they require invasive
and expensive testing. Finally, there are likely to be cohort specific
effects on our results; these findings need to be replicated in other
cohorts to assess their generalizability. Nevertheless, these human
observations are important to inform more mechanist investiga-
tions on the Th2 response to tuberculosis in animal models.
Another important line of investigation informed by these
results is to develop non-invasive screening tests for Th2
predominant response in TB. Such a test could stratify the risk
of transmission; a critical issue with MDR-TB. Some possibilities
include cytokine measures on expectorated sputum or cytokine
elaboration in blood stimulated with TB antigens. It date,
interferon gamma release assays are clinically useful for assessing
TB exposure. IL-4 or IL-12p40 release assays done in parallel may
add important information that can prioritize patients for
chemoprophylaxis.
Conclusion
Increased production of the Th2 cytokine IL-4 by BAL cells is a
strong risk factor for TB transmission in this South African cohort.
Further investigation of Th2 immune pathways in TB are needed
to improve our understanding of immune states that predispose to
TB transmission and develop a clinical useful screening test for a
Th2 predominant immune response.
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